Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132929) titled 'Antiviral Treatment Strategies to Improve the Clinical Cure Rate and Reduce the Relapse Rate of Chronic Hepatitis B' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Chronic Hepatitis B
Intervention:
Novel Dual-Adjuvant Vaccine Group:Receive the novel dual-adjuvant hepatitis B vaccine combination regimen.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-21
Target Sample Size: Novel Dual-Adjuvant Vaccine Group:48;Conventional Hepatitis B Vaccine Group:48;
Countries of Recruitment:
Chin...